KAD-75601-45916
3 vaccinations
1 coded response
23 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 483 / MI
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-02-11
Dose 2 — Pfizer-BioNTech
-
2021-02-21
Registered in v-safe
- 2021-02-21
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-05-13
- 2021-08-12
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-29
- 2021-11-03
- 2021-11-11
-
2021-12-29
Survey response — 3 months, dose 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Runny nose and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-03-30
- 2022-09-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Runny nose and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release